中性粒细胞与淋巴细胞比值与食管鳞癌患者临床病理特征的相关性及其在预后评估中的价值分析

雷蕾; 李旭; 贺建华; 黄进启; 周翔禹; 向水

doi:10.3969/j.issn.1671-038X.2018.01.06

中性粒细胞与淋巴细胞比值与食管鳞癌患者临床病理特征的相关性及其在预后评估中的价值分析

- 1 湖北省恩施土家族苗族自治州中心医院消化内科, 湖北恩施 445000;
- 2 湖北省恩施土家族苗族自治州中心医院心胸外科, 湖北恩施 445000

详细信息

作者简介:
雷蕾,女,副主任医师,硕士研究生。研究方向:食管癌

通讯作者: 李旭,E-mail:wyxj626763389@163.com

中图分类号: R735.1

收稿日期: 2017-08-12

Correlation between neutrophil to lymphocyte ratio and clinicopathological features of patients with esophageal squamous cell carcinoma and its value in prognostic evaluation

- 1 Department of Gastroenterology, Enshi Tujia and Miao Autonomous Prefecture Central Hospital, Hubei, Enshi 445000, China;
- 2 Department of Cardiothoracic Surgery, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Hubei, Enshi 445000, China

More Information

Corresponding author: LI Xu, E-mail: wyxj626763389@163.com

Received Date: 12 August 2017

摘要

摘要: [目的]旨在探讨术前中性粒细胞与淋巴细胞比值 (NLR) 与食管鳞癌患者临床病理特征的相关性及其在预后评估中的价值。[方法]收集我院2010年1月~2011年12月收治的103例食管鳞癌患者的临床资料进行回顾性分析。根据患者NLR水平, 将患者分为低NLR组 (NLR＜2.23, n=60) 及高NLR组 (NLR ≥ 2.23, n=43), 比较2组患者的临床病理特征, 采用Cox回归分析模型探讨影响食管鳞癌预后的独立危险因素。[结果]高NLR组TNM分期Ⅲ期者、未分化+低分化者比例明显高于多于NLR组, 差异有统计学意义 (P＜0.01);低NLR组3年、5年总生存率分别为58.33% (35/60)、36.66% (22/60), 明显低于高NLR组37.20% (16/43)、18.60% (8/43), 差异有统计学意义 (P＜0.05);TNM分期、肿瘤分化程度、治疗方式、NLR值是影响食管鳞癌患者预后生存的单因素 (P＜0.01), 进一步经Cox回归分析后显示, TNM分期 (Ⅲ期)、肿瘤分化程度 (未分化+低分化)、治疗方式 (单纯手术)、NLR值 (≥ 2.23) 是影响食管鳞癌患者预后生存的独立危险因素 (P＜0.01)。[结论]术前NLR比值水平可作为食管鳞癌患者预后的评估指标, 术前高NLR水平者其预后不佳。
- 中性粒细胞与淋巴细胞比值 /
- 食管鳞癌 /
- 临床病理特征 /
- 预后
Abstract: [Objective] To investigate the correlation between neutrophil to lymphocyte ratio and clinicopathological features of patients with esophageal squamous cell carcinoma and its value in prognostic evaluation.[Methods] The clinical data of 103 patients with esophagus squamous cell carcinoma treated in our hospital from January 2010 to December 2011 were retrospectively analyzed.According to the level of NLR patients, the patients were divided into low NLR group (NLR＜2.23, n=60) and high NLR group (NLR ≥ 2.23, n=43).The clinical and pathological features of two groups were compared.Cox regression analysis was used to explore the influence of independent risk factors for the prognosis of esophageal squamous cell carcinoma.[Results] The proportion of TNM stage III, undifferentiated and low differentiation in high NLR group were significantly higher than that of NLR group, the difference was statistically significant (P＜0.001).The 3 years and 5 years total survival rates in low NLR group were 58.33% (35/60) and 36.66% (22/60) respectively, which were significantly lower than that in high NLR group[37.20% (16/43) and18.60% (8/43)], the difference were statistically significant (P＜0.05).The single factors influencing the prognosis of patients with esophageal squamous cell carcinoma included TNM stage, tumor differentiation, treatment and NLR value (P＜0.01).Cox regression analysis showed that TNM stage (stage III), tumor differentiation degree (undifferentiated and low differentiated) and the way of treatment (surgery), NLR value (≥ 2.23) were independent risk factors for survival prognosis of patients with esophageal squamous cell carcinoma (P＜0.01).[Conclusion] Preoperative NLR can be used as an indicator of prognosis in patients with esophagus squamous cell carcinoma.The prognosis of patients with high preoperative NLR is poor.
- Neutrophil to lymphocyte ratio /
- Esophageal squamous cell carcinoma /
- Clinicopathological features /
- Prognosis

HTML全文

参考文献(20)

[1]	苏子剑, 潘群雄, 王聪仁, 等.术前中性粒细胞/淋巴细胞比值预测食管癌患者预后的价值[J].肿瘤, 2015, 35 (11):1258-1264.
[2]	刘雪梅, 李明焕, 孔莉, 等.外周血中性粒细胞与淋巴细胞比值对根治性放化疗食管鳞癌患者预后预测价值[J].中华肿瘤防治杂志, 2016, 23 (21):1431-1436.
[3]	张金野, 陈永东, 周明.胸中下段食管鳞癌左开胸根治术前中性粒细胞与淋巴细胞比值对预后的评估价值[J].现代肿瘤医学, 2017, 25 (7):1061-1064.
[4]	王永连, 赵英政, 徐光翠, 等.血清肿瘤标志物水平及其联合检测对食管癌的诊断意义[J].重庆医学, 2016, 44 (3):419-420.
[5]	李林峻, 吴庆琛, 张敏, 等.影响食管癌患者预后因素的Cox回归分析[J].重庆医学, 2016, 44 (1):66-68.
[6]	曾传彪, 杨树宏, 许方程, 等.术前中性粒细胞/淋巴细胞比值与胃癌患者病理特征及其预后的相关性研究[J].解放军预防医学杂志, 2017, 35 (2):156-158.
[7]	魏英, 王小林, 马任远, 等.术前外周血中性粒细胞/淋巴细胞比值对胃癌患者预后的影响[J].陕西医学杂志, 2015, 43 (1):65-67.
[8]	郑奇志, 张剑锋, 谢湛荣, 等.中性粒细胞/淋巴细胞比值和胰岛素样生长因子-1在胃癌中的变化及诊断意义[J].中国中西医结合消化杂志, 2015, 23 (6):394-396.
[9]	张兴, 李森, 郭忠武, 等.75岁以上老年胃癌患者术前外周血中性粒细胞与淋巴细胞比值的临床意义[J].中华胃肠外科杂志, 2016, 19 (5):526-529.
[10]	Kijima T, Arigami T, Uchikado Y, et al.Combined Fibrinogen and Neutrophil-Lymphocyte Ratio as a Prognostic Marker of Advanced Esophageal Squamous Cell Carcinoma[J].Cancer Science, 2017, 108 (2):125-125.
[11]	赵海龙, 薛继军, 郑凤长, 等.食管癌术后生存五年以上患者复发转移的相关因素分析[J].中国胸心血管外科临床杂志, 2016, 22 (6):546-549.
[12]	李晨, 杜晓辉, 徐迎新, 等.胃癌患者术前中性粒细胞淋巴细胞比率与淋巴结转移相关性临床研究[J].医学研究杂志, 2015, 44 (1):93-97.
[13]	Yutong H, Xiaoli X, Shumei L, et al.Increased Neutrophil-Lymphocyte Ratio Is a Poor Prognostic Factor in Patients with Esophageal Cancer in a High Incidence Area in China[J].Archives of Medical Research, 2015, 46 (7):557-563.
[14]	杜娟, 邬麟, 陈柏林, 等.食管癌的主要发病因素及其机制[J].中国医药导报, 2017, 14 (7):40-44.
[15]	吴勇, 余南彬.食管癌患者血浆及肿瘤组织中核黄素含量检测及其临床病理意义评估[J].海南医学院学报, 2016, 22 (12):1307-1310.
[16]	孙宝林, 余守强, 甄福喜.食管癌术前血浆肿瘤标志物检测的临床意义[J].现代肿瘤医学, 2016, 23 (1):52-54.
[17]	Yodying H, Matsuda A, Miyashita M, et al.Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer:A Systematic Review and Metaanalysis[J].Ann Surg Oncol, 2015, 23 (2):1-9.
[18]	Arigami T, Okumura H, Matsumoto M, et al.Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma:A Promising Blood Marker of Tumor Progression and Prognosis.[J].Medicine, 2015, 94 (42):1702-1702
[19]	赵斯俊, 刘迪填, 陈于平.全身炎症反应与食管癌预后[J].国际肿瘤学杂志, 2016, 43 (4):124-125.
[20]	王强强, 张玉虹, 刘阳晨.血常规相关指标与食管癌患者治疗效果和预后的关系[J].现代肿瘤医学, 2016, 24 (14):2318-2322.